Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors von Marty, Caroline, Saint-Martin, Cécile, Pecquet, Christian, Grosjean, Sarah, Saliba, Joseph, Mouton, Céline, Leroy, Emilie, Harutyunyan, Ashot S., Abgrall, Jean-François, Favier, Rémi, Toussaint, Aurélie, Solary, Eric, Kralovics, Robert, Constantinescu, Stefan N., Najman, Albert, Vainchenker, William, Plo, Isabelle, Bellanné-Chantelot, Christine

Volltext

Analysis of the Ten-Eleven Translocation 2 (TET2) gene in familial myeloproliferative neoplasms von Saint-Martin, Cécile, Leroy, Gwendoline, Delhommeau, François, Panelatti, Gérard, Dupont, Sabrina, James, Chloé, Plo, Isabelle, Bordessoule, Dominique, Chomienne, Christine, Delannoy, André, Devidas, Alain, Gardembas-Pain, Martine, Isnard, Françoise, Plumelle, Yves, Bernard, Olivier, Vainchenker, William, Najman, Albert, Bellanné-Chantelot, Christine

Volltext

Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera von Swierczek, S. I., Yoon, D., Bellanne-Chantelot, C., Kim, S. J., Saint-Martin, C., Delhommeau, F., Najman, A., Prchal, J. T.

Volltext

Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies von Saliba, Joseph, Saint-Martin, Cécile, Di Stefano, Antonio, Lenglet, Gaëlle, Marty, Caroline, Keren, Boris, Pasquier, Florence, Valle, Véronique Della, Secardin, Lise, Leroy, Gwendoline, Mahfoudhi, Emna, Grosjean, Sarah, Droin, Nathalie, Diop, M'boyba, Dessen, Philippe, Charrier, Sabine, Palazzo, Alberta, Merlevede, Jane, Meniane, Jean-Côme, Delaunay-Darivon, Christine, Fuseau, Pascal, Isnard, Françoise, Casadevall, Nicole, Solary, Eric, Debili, Najet, Bernard, Olivier A, Raslova, Hana, Najman, Albert, Vainchenker, William, Bellanné-Chantelot, Christine, Plo, Isabelle

Volltext

An inherited gain‐of‐function risk allele in EPOR predisposes to familial JAK2 V617F myeloproliferative neoplasms von Rabadan Moraes, Graciela, Pasquier, Florence, Marzac, Christophe, Deconinck, Eric, Damanti, Carlotta Caterina, Leroy, Gwendoline, El-Khoury, Mira, El Nemer, Wassim, Kiladjian, Jean‐jacques, Raslova, Hana, Najman, Albert, Vainchenker, William, Marty, Caroline, Bellanné-Chantelot, Christine, Plo, Isabelle

Volltext

An inherited gain‐of‐function risk allele in EPOR predisposes to familial JAK2V617F myeloproliferative neoplasms von Rabadan Moraes, Graciela, Pasquier, Florence, Marzac, Christophe, Deconinck, Eric, Damanti, Carlotta Caterina, Leroy, Gwendoline, El‐Khoury, Mira, El Nemer, Wassim, Kiladjian, Jean‐Jacques, Raslova, Hana, Najman, Albert, Vainchenker, William, Marty, Caroline, Bellanné‐Chantelot, Christine, Plo, Isabelle

Volltext

An inherited gain-of-function risk allele in EPOR predisposes to familial JAK2 V617F myeloproliferative neoplasms von Rabadan Moraes, Graciela, Pasquier, Florence, Marzac, Christophe, Deconinck, Eric, Damanti, Carlotta Caterina, Leroy, Gwendoline, El-Khoury, Mira, El Nemer, Wassim, Kiladjian, Jean-Jacques, Raslova, Hana, Najman, Albert, Vainchenker, William, Marty, Caroline, Bellanné-Chantelot, Christine, Plo, Isabelle

Volltext

Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications von Malak, Sandra, Labopin, Myriam, Saint-Martin, Cecile, Bellanne-Chantelot, Christine, Najman, Albert

Volltext

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders von Bellanné-Chantelot, Christine, Chaumarel, Isabelle, Labopin, Myriam, Bellanger, Florence, Barbu, Véronique, De Toma, Claudia, Delhommeau, François, Casadevall, Nicole, Vainchenker, William, Thomas, Gilles, Najman, Albert

Volltext

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation von Colombat, Philippe, Salles, Gilles, Brousse, Nicole, Eftekhari, Pitahey, Soubeyran, Piere, Delwail, Vincent, Deconinck, Eric, Haı̈oun, Corinne, Foussard, Charles, Sebban, Catherine, Stamatoullas, Astasia, Milpied, Noël, Boué, François, Taillan, Bruno, Lederlin, Pierre, Najman, Albert, Thièblemont, Catherine, Montestruc, François, Mathieu-Boué, Anne, Benzohra, Aziz, Solal-Céligny, Philippe

Volltext

Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol von Moreau, Philippe, Hullin, Cyrille, Garban, Frédéric, Yakoub-Agha, Ibrahim, Benboubker, Lotfi, Attal, Michel, Marit, Gérald, Fuzibet, Jean-Gabriel, Doyen, Chantal, Voillat, Laurent, Berthou, Christian, Ketterer, Nicolas, Casassus, Philippe, Monconduit, Mathieu, Michallet, Mauricette, Najman, Albert, Sotto, Jean-Jacques, Bataille, Régis, Harousseau, Jean-Luc

Volltext

Necrotic and ulcerated cutaneous and mucosal leukemia cutis in AML6 von Bachmeyer, Claude, Buffet, Marc, Moguelet, Philippe, Najman, Albert, Aractingi, Sélim

Volltext

Germline JAK2 Mutations In The Kinase Domain Are Responsible For Hereditary Thrombocytosis and Are Resistant To JAK2 and HSP90 Inhibitors von Marty, Caroline, Saint-martin, Cecile, Pecquet, Christian, Grosjean, Sarah, Saliba, Joseph, Mouton, Celine, Emilie, Leroy, Harutyunyan, Ashot S., Abgrall, Jean-François, Favier, Remy, Solary, Eric, Kralovics, Robert, Constantinescu, Stefan N., Najman, Albert, Vainchenker, William, Plo, Isabelle, Bellanné-Chantelot, Christine

Volltext

Long-Term Follow-up of 94 Families with Myeloproliferative Neoplasms: Implications of the V617F JAK2 mutation, Life Expectancy and Complication Rates von Malak, Sandra, Labopin, Myriam, Chaumarel, Isabelle, Saint-Martin, Cecile, Bellanne-Chantelot, Christine, Najman, Albert

Volltext

TET2 Mutations in Polycythemia Vera (PV) in Some Cases Follow Rather Than Precede JAK2 V617F Mutation, Are Not a Disease-Initiating Event, Affect Mainly Erythropoiesis, and Contrib... von Swierczek, Sabina, Bellanne-Chantelot, Christine, Yoon, Donghoon, Saint-Martin, Cecile, Kim, Soo Jin, Najman, Albert, Prchal, Josef T.

Volltext

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma : A randomized multicenter study von ÖSTERBORG, A, BOOGAERTS, M. A, CIMINO, R, ESSERS, U, HOLOWIECKI, J, JULIUSSON, G, JÄGER, G, NAJMAN, A, PEEST, D

Volltext

Recombinant Human Erythropoietin in the Anemia Associated With Multiple Myeloma or Non-Hodgkin’s Lymphoma: Dose Finding and Identification of Predictors of Response von Cazzola, Mario, Messinger, Diethelm, Battistel, Vittorio, Bron, Dominique, Cimino, Renato, Enller-Ziegler, Liana, Essers, Ute, Greil, Richard, Grossi, Alberto, Jäger, Gerard, LeMevel, Annick, Najman, Albert, Silingardi, Vittorio, Spriano, Mauro, Hoof, Achiel van, Ehmer, Bernhard

Volltext

Schizocytosis in pernicious anemia mimicking thrombotic thrombocytopenic purpura von Garderet, Laurent, Maury, Eric, Lagrange, Monique, Najman, Albert, Offenstadt, Georges, Guidet, Bertrand

Volltext

Interest of NT-proBNP To Detect Chemotherapy Regimens Cardiotoxicity in Patients with Hematological Malignancies: Preliminary Results von Dine, Gerard, Genty, Vincent, Brahimi, Said, Ammar, Nadia Ali, Mendes, William, Rehn, Yves, Najman, Albert

Volltext

Study of V617F JAK2-Positive and JAK2-Negative Patients within 18 Families with Myeloproliferative Disorders (MPD): Disease Characteristics and Evolution, EPOR and MPL Analysis von Bellanne-Chantelot, Christine, Labopin, Myriam, Bellanger, Florence, Chaumarel, Isabelle, Isnard, Françoise, Casadevall, Nicole, Vainchenker, William, Thomas, Gilles, Najman, Albert

Volltext